AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 213 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,361,869 | -30.9% | 55,025 | -21.0% | 0.00% | -100.0% |
| Q2 2023 | $1,971,639 | +235.7% | 69,620 | +172.3% | 0.00% | – |
| Q1 2023 | $587,366 | -29.6% | 25,571 | -13.9% | 0.00% | – |
| Q4 2022 | $834,425 | -25.4% | 29,716 | -41.1% | 0.00% | – |
| Q2 2022 | $1,119,000 | -28.0% | 50,479 | -5.5% | 0.00% | – |
| Q1 2022 | $1,555,000 | -82.7% | 53,438 | -80.4% | 0.00% | -100.0% |
| Q4 2021 | $8,969,000 | -26.8% | 272,899 | +2.7% | 0.00% | -25.0% |
| Q3 2021 | $12,259,000 | -15.1% | 265,645 | +1.4% | 0.00% | -33.3% |
| Q2 2021 | $14,432,000 | +39.2% | 261,875 | +30.4% | 0.01% | 0.0% |
| Q1 2021 | $10,370,000 | -20.0% | 200,813 | -32.9% | 0.01% | 0.0% |
| Q4 2020 | $12,959,000 | +111.5% | 299,067 | +70.8% | 0.01% | +100.0% |
| Q3 2020 | $6,128,000 | -26.6% | 175,056 | +12.1% | 0.00% | -40.0% |
| Q2 2020 | $8,349,000 | +1362.2% | 156,117 | +869.7% | 0.01% | – |
| Q1 2020 | $571,000 | -70.4% | 16,100 | -60.2% | 0.00% | -100.0% |
| Q4 2019 | $1,932,000 | +355.7% | 40,458 | +209.5% | 0.00% | +200.0% |
| Q3 2019 | $424,000 | +12.8% | 13,071 | +134.3% | 0.00% | 0.0% |
| Q1 2019 | $376,000 | -77.2% | 5,578 | -74.0% | 0.00% | -75.0% |
| Q3 2018 | $1,652,000 | +80.7% | 21,413 | +97.3% | 0.00% | +100.0% |
| Q2 2018 | $914,000 | +294.0% | 10,852 | +141.2% | 0.00% | +100.0% |
| Q2 2017 | $232,000 | -88.3% | 4,500 | -88.0% | 0.00% | -90.0% |
| Q3 2016 | $1,982,000 | +458.3% | 37,527 | +329.1% | 0.01% | +400.0% |
| Q1 2016 | $355,000 | +19.9% | 8,746 | +228.7% | 0.00% | 0.0% |
| Q2 2015 | $296,000 | -75.3% | 2,661 | -75.1% | 0.00% | -77.8% |
| Q4 2014 | $1,198,000 | +87.8% | 10,692 | -23.3% | 0.01% | +12.5% |
| Q2 2014 | $638,000 | – | 13,933 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |